BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 16896953)

  • 1. Dopamine receptor stimulation does not modulate the loudness dependence of the auditory evoked potential in humans.
    O'Neill BV; Croft RJ; Leung S; Guille V; Galloway M; Phan KL; Nathan PJ
    Psychopharmacology (Berl); 2006 Sep; 188(1):92-9. PubMed ID: 16896953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute dopamine D(1) and D(2) receptor stimulation does not modulate mismatch negativity (MMN) in healthy human subjects.
    Leung S; Croft RJ; Baldeweg T; Nathan PJ
    Psychopharmacology (Berl); 2007 Nov; 194(4):443-51. PubMed ID: 17611739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dopamine receptor affinities in vitro and stereotypic activities in vivo of cabergoline in rats.
    Miyagi M; Itoh F; Taya F; Arai N; Isaji M; Kojima M; Ujiie A
    Biol Pharm Bull; 1996 Sep; 19(9):1210-3. PubMed ID: 8889042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of selective and combined serotonin and dopamine depletion on the loudness dependence of the auditory evoked potential (LDAEP) in humans.
    O'Neill BV; Guille V; Croft RJ; Leung S; Scholes KE; Phan KL; Nathan PJ
    Hum Psychopharmacol; 2008 Jun; 23(4):301-12. PubMed ID: 18213738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The modulatory effects of dopamine D1 and D2 receptor function on object working memory in humans.
    Bartholomeusz CF; Box G; Van Rooy C; Nathan PJ
    J Psychopharmacol; 2003 Mar; 17(1):9-15. PubMed ID: 12680735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-dose glycine inhibits the loudness dependence of the auditory evoked potential (LDAEP) in healthy humans.
    O'Neill BV; Croft RJ; Leung S; Oliver C; Phan KL; Nathan PJ
    Psychopharmacology (Berl); 2007 Nov; 195(1):85-93. PubMed ID: 17646968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional potencies of new antiparkinsonian drugs at recombinant human dopamine D1, D2 and D3 receptors.
    Perachon S; Schwartz JC; Sokoloff P
    Eur J Pharmacol; 1999 Feb; 366(2-3):293-300. PubMed ID: 10082211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dopamine agonists used in the treatment of Parkinson's disease and their selectivity for the D1, D2, and D3 dopamine receptors in human striatum.
    De Keyser J; De Backer JP; Wilczak N; Herroelen L
    Prog Neuropsychopharmacol Biol Psychiatry; 1995 Nov; 19(7):1147-54. PubMed ID: 8787038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined D1/D2 receptor stimulation under conditions of dopamine depletion impairs spatial working memory performance in humans.
    Ellis KA; Mehta MA; Wesnes KA; Armstrong S; Nathan PJ
    Psychopharmacology (Berl); 2005 Oct; 181(4):771-80. PubMed ID: 15983794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Agonistic actions of pergolide on firing activity of dopamine neurons in substantia nigra compacta area.
    Zhang XX; Jin GZ; Wei YF
    Zhongguo Yao Li Xue Bao; 1995 Sep; 16(5):423-7. PubMed ID: 8701759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Examination of the effect of acute levodopa administration on the loudness dependence of auditory evoked potentials (LDAEP) in humans.
    Hitz K; Heekeren K; Obermann C; Huber T; Juckel G; Kawohl W
    Psychopharmacology (Berl); 2012 Jun; 221(3):389-96. PubMed ID: 22119935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic effects of dopamine D1/D2 receptor agonists on detrusor hyperreflexia in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned parkinsonian cynomolgus monkeys.
    Yoshimura N; Mizuta E; Yoshida O; Kuno S
    J Pharmacol Exp Ther; 1998 Jul; 286(1):228-33. PubMed ID: 9655864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic modulation of serotonergic neurotransmission with sertraline attenuates the loudness dependence of the auditory evoked potential in healthy participants.
    Simmons JG; Nathan PJ; Berger G; Allen NB
    Psychopharmacology (Berl); 2011 Sep; 217(1):101-10. PubMed ID: 21465243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative effects of repeated administration of dopamine agonists on circling behavior in rats.
    Prikhojan A; Brannan T; Yahr MD
    J Neural Transm (Vienna); 2000; 107(10):1159-64. PubMed ID: 11129105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. D1- versus D2-receptor modulation of visuospatial working memory in humans.
    Müller U; von Cramon DY; Pollmann S
    J Neurosci; 1998 Apr; 18(7):2720-8. PubMed ID: 9502829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pergolide: a dopamine agonist at both D1 and D2 receptors.
    Fuller RW; Clemens JA
    Life Sci; 1991; 49(13):925-30. PubMed ID: 1832202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence for sex differences in the loudness dependence of the auditory evoked potential in humans.
    Oliva JL; Leung S; Croft RJ; O'Neill BV; Stout JC; Nathan PJ
    Hum Psychopharmacol; 2011 Mar; 26(2):172-6. PubMed ID: 21455974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation by group I mGLU receptor activation and group III mGLU receptor blockade of locomotor responses induced by D1-like and D2-like receptor agonists in the nucleus accumbens.
    Rouillon C; Degoulet M; Chevallier K; Abraini JH; David HN
    Brain Res; 2008 Mar; 1198():44-54. PubMed ID: 18261716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The loudness dependence of the auditory evoked potential (LDAEP) as an in vivo biomarker of central serotonergic function in humans: rationale, evaluation and review of findings.
    O'Neill BV; Croft RJ; Nathan PJ
    Hum Psychopharmacol; 2008 Jul; 23(5):355-70. PubMed ID: 18421800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential dopaminergic modulation of executive control in healthy subjects.
    Roesch-Ely D; Scheffel H; Weiland S; Schwaninger M; Hundemer HP; Kolter T; Weisbrod M
    Psychopharmacology (Berl); 2005 Apr; 178(4):420-30. PubMed ID: 15765257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.